Hello Friends! In today’s episode 🎙️, we take a look at Pfizer (ticker symbol: PFE), a stock down +30% down year to day with a dividend above to 6%. Many people have been trying to call the bottom. Is Pfizer ($PFE) a great value stock to buy now, or is it a value trap?

📊 Grab our excel sheet: ⁠⁠⁠https://www.buymeacoffee.com/MoneyTalkswithMartinReyes⁠⁠⁠

👍 Engage & Collaborate: Share your insights, bear/bull cases, and stock suggestions in the comments! Don't forget to like, subscribe, and hit the notification bell.

🔍 Important Disclaimer: I am not a financial advisor. Content is for educational purposes. Invest responsibly. Some links are affiliate.

📌 COMPANY PROFILE:

Pfizer (PFE) is a global biopharmaceutical company engaged in the discovery, development, manufacturing, and distribution of a wide range of medicines and vaccines. Their diverse portfolio includes products addressing therapeutic areas such as cardiovascular metabolic, migraine, and women's health. Notably, the company has been at the forefront of COVID-19 prevention and treatment with brands like Comirnaty and Paxlovid, and it explores potential future mRNA and antiviral products.

🔖 Tags: #PFE #Pfizer #StockAnalysis #ValueInvesting #GrowthInvesting #Investing 🎙️

048. Is Pfizer (PFE) Stock a Buy Now at 52 Week Lows or a Value Trap? | Stock Analysis & New Fair Value 19:33 Share

Money Talks with Martin Reyes

Shownotes Transcript

048. Is Pfizer (PFE) Stock a Buy Now at 52 Week Lows or a Value Trap? | Stock Analysis & New Fair Value